je.st
news
Tag: therapy
Barn dance boosts therapy program
2014-06-22 09:26:36| Beverages - Topix.net
Scott Kozel, vice president of coastal winemaking for E.&J. Gallo Winery, led guests through a tour of wines paired with a five-course meal prepared by Chef Michael Wilson of Ella's Restaurant in Fayetteville and served on the stage in Baum Walker Hall.
Tags: program
dance
therapy
barn
Proton Therapy System features single-room design.
2014-06-20 14:31:09| Industrial Newsroom - All News for Today
Suitable for adoption into existing cancer centers, ProBeam® Compact includes space-efficient cyclotron, Dynamic Peak™ scanning technology for intensity-modulated proton therapy, fully rotational gantry, robotic patient positioning tools, and comprehensive suite of motion management tools. System also incorporates integrated 2- and 3-D imager for real-time image guidance, as well as option of planning and managing treatments using Eclipse™ and ARIA® software systems. This story is related to the following:Medical Equipment & Supplies |
Tags: system
design
features
therapy
Game changers ImmunoGen's breast cancer therapy took time
2014-06-15 04:30:26| Biotech - Topix.net
Patients and doctors applauded last year when the powerful new breast cancer therapy Kadcyla made its market debut, following a long and winding journey to approval for what many view as a miracle medicine.
Tags: time
game
cancer
therapy
Late-Breaking Observational Data Show Patients with Type 2 Diabetes Taking JANUVIA (sitagliptin) and Metformin Initiated Insulin Therapy at a Slower Rate Compared to Patients Taking a Sulfonylurea and Metformin
2014-06-14 19:01:32| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION Real-world study presented at the American Diabetes Association 74th Scientific Sessions Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a late-breaking observational study that assessed the differences in time to initiation of insulin use and the proportion of the population initiating insulin among patients with type 2 diabetes taking the combination of JANUVIA (sitagliptin) and metformin, and patients taking the combination of a sulfonylurea and metformin. In this study, patients treated with a combination of JANUVIA and metformin initiated insulin therapy at a slower rate during the period of observation than patients Language: English read more
New Post-Hoc Analysis Shows Patients with Type 2 Diabetes Undergoing Intensification of Insulin Therapy Experienced Less Nighttime Hypoglycemia While Being Treated with JANUVIA (sitagliptin) Compared to Placebo
2014-06-14 19:01:06| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) hypoglycemia compared to patients also receiving placebo. Results were presented at the American Diabetes Association 74th Scientific Sessions. Language: English read more
Sites : [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] next »